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ABSTRACT: The aim of this study was to evaluate the effectiveness of an asthma
education programme in moderate and severe asthma patients in a longitudinal,
prospective and randomized study with a control group. Fifty-three asthmatic
patients were studied, 26 of whom were assigned to the educational group and 27 to
the control group.
The educational group attended the programme regularly for a period of 6 months.
The programme included information about asthma, instruction on the appropriate
use of medication and training in the metered dose inhaler (MDI) technique, and
information about the identification and control of asthma attacks and the recognition
of early signs of exacerbation. The control group was submitted to the routine care
provided at the Asthma Clinic, with no formal instruction regarding asthma control.
The groups were identical with regard to severity parameters, skills, lung function and
quality of life at the beginning of the trial.
At the end of the study, the education group showed significant differences when
compared with the control group (education/control (mean values)) with respect to:
visits to the asthma emergency room over the previous 6 months, 0.7/2 (p=0.03);
nocturnal symptoms, 0.3/0.7 (p=0.04); score of symptoms, 1.3/2 (p=0.04). Improve-
ments were also observed in skills and quality of life, knowledge of how to deal with
attacks and how to control the environmental triggering factors, 73/35 (<0.05); correct
use of the MDI, 8/4 (0.001); understanding of the difference between relief and anti-
inflammatory medication, 86/20 (<0.05); and in the global limitation quality of life
score, 28/50 (0.02).
It is concluded that the educational programme led to a significant improvement in
asthma morbidity and that the implantation of educational programmes is possible
for special populations when these programmes are adapted to the socioeconomic
profile of the patients, with a significant gain in terms of the reduction of symptoms
and improved pulmonary function and quality of life of asthmatics.
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Asthma treatment has not led to impressive changes in
morbidity and mortality, despite more knowledge about the
inflammatory process involved in asthmatic airways, foll-
owed by the development of new drugs [1, 2]. In many
countries, an increase in the rate of emergency room (ER)
visits and hospitalizations, as well as loss of school days
and/or work days due to asthma, has shown the difficulty
in providing adequate control of the disease. This is es-
pecially true when the studies are conducted on target
populations with special characteristics such as poor and
minority children in inner cities and socially deprived
populations [3±6].
The International Consensus Report on Diagnosis and
Management of Asthma (ICRDMA) [7] concluded in its
guidelines that education is one of the critical components
of asthma treatment. Few controlled randomized trials
have been carried out to evaluate educational programmes
in socially deprived asthmatic populations [8±11] and
efforts to measure the value of education in terms of
morbidity have been hampered by the lack of control
groups.
MAYO et al. [8] performed a randomized trial involving
a population with socioeconomic problems and demon-
strated a reduction in hospital readmission rates and
hospital day use rates. KELSO et al. [9] reported a 41%
reduction in ER visits by indigent minorities. The same
investigator, studying African Americans in a nonrando-
mized control trial, reported significant reductions in the
morbidity of asthma [10]. In New Zealand, D'SOUZA et al.
[11] introduced a credit-card self-management plan in a
Maori community, with a significant reduction in the
morbidity of asthma. However, this was a nonrandomized
control trial.
Asthma is the fourth largest cause of hospital admission
in Brazil (1996). It was reported to be the primary cause of
hospitalization for patients aged 20±29 yrs, causing dis-
ability with great social and economic impact on the pro-
ductive population [12]. The present study was designed
as a randomized controlled trial to assess the effectiveness
of population-based asthma management intervention
and was especially tailored for deprived low-income
populations of poor social and cultural backgrounds. This
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6 month educational programme has already been imple-
mented in a deprived population with good results [13].
Methods
Patients
The study was conducted at the asthma outpatient clinic
of the Lung Division, Federal University of SaÄo Paulo
(UNIFESP-EPM)-Brazil, and was approved by the Human
Investigation Ethical Committee of the Institution.
The patients were recruited from a computer database of
asthma outpatients (n=450). Eighty patients were selected
and invited for an interview in which they were informed
about the purpose of the study, as well as its duration and
the chance to be placed in an educational or a control
group; written consent was obtained. The patients who
agreed to participate in the study were randomly assigned
to one of these groups via the closed envelope technique.
A total of 53 patients with asthma confirmed by history
and airflow, obstruction according to the criteria of the
ICRDMA [7] were eligible to participate in the trial.
Study design
The patients were included in the trial and monitored at
an outpatient clinic for 6 months; 26 of the patients were
assigned to the educational group and 27 to the control
group, in February±July 1996. All patients were submitted
to the interview at the beginning and at the end of the study
for assessment of the outcome measures.
Both groups were attended in the asthma outpatient de-
partment by the same team of physicians who were
pneumologists in training under the supervision of Uni-
versity staff physicians.
Forms were provided by the physician for the patient to
fill in, showing the frequency of diurnal and nocturnal
asthma symptoms over the previous 3 weeks before the
interview. Associated symptoms, exacerbations, current
use of asthma medication, and physical examination data
were recorded, and treatment was adjusted for each patient
based on the ICRDMA [7] recommendations. These
recommendations emphasize the reduction of symptom-
based therapy and the increased use of anti-inflammatory
drugs to control underlying inflammation. Patients were
taught to control mild to moderate symptoms with relief
medication "as needed".
Both groups received a prescription for the medication
indicated for their clinical presentation. The health
department did not provide the drugs which had to be
purchased by the patient. The professional team did not
interfere with this but encouraged the patients to follow the
prescribed treatment.
The educational group
The patients assigned to the educational group were
divided into four subgroups and each subgroup was
scheduled for a monthly visit over a period of 6 months.
On the occasion of the first visit, the investigators
explained the difference between relief and anti-inflam-
matory medications on an individual basis. Simple diary
cards were given to the patients, on which they had to tick
"Yes" or "No" with respect to the occurrence of diurnal and
nocturnal symptoms, thus improving their perception of
asthma symptoms. When the patient was unable to fill out
the diary card, someone in the family was requested to help
them. At each follow-up visit the diary card was reviewed
and discussed with the patient to stress the importance of
management of the disease, and the treatment plan was
readjusted according to the frequency of symptoms and the
necessity of use of relief medication.
The use of the metered dose inhaler (MDI) was checked
and the patient was retrained as necessary at each visit.
After consultation, a staff member of the asthma group
explained the use of the prescribed drugs to each patient,
sharing patient care responsibility and encouraging com-
pliance with treatment.
Two 1 h sessions were scheduled after the third and
fourth monthly visits, in which the patients in each sub-
group received information about the concept of asthma
and its management. The information covered signs and
symptoms of exacerbation, triggering factors and environ-
mental control, and some notions on relief (bronchodilator)
and on preventive (anti-inflammatory) medication. A
videotape produced by the investigators emphasized typ-
ical problems such as misconceptions about asthma, correct
inhaler techniques and the introduction to a treatment plan
based on the "abc" of asthma: a) identifying and reducing
the factors that trigger asthma attacks, b) correct use of
inhalers and spacers, and c) recognizing the warning signs
of asthma episodes. The patients were encouraged to par-
ticipate, to exchange information and to clarify their doubts
about the disease. Reading material was distributed with
information about asthma and diary cards were provided
with the purpose of improving the perception of asthma
symptoms during the daily routine.
Because the patients had problems in identifying their
medication they were encouraged to bring their medica-
tions to the clinic visits where the difference between relief
and prevention drugs was explained using visual aids (i.e.
posters)
Control group
The control group followed the routine schedule of the
Asthma Clinic, where their next follow-up appointment
was determined by the attending physician according to
individual patient needs. The number of visits for this
group ranged 2±5 and the therapy was personalized for
each patient based on the ICRDMA recommendations [7].
The patients did not receive formal instructions regarding
asthma control nor did they fill out diary cards. They did
not receive MDI training sessions or information about
environmental control and early recognition of warning
signs of asthma using posters, discussion sessions or
video presentations. The control group only received
instructions from the consulting physician. Regarding the
use of medication and of the inhaler, they received only a
verbal explanation.
Outcome measures
The outcomes of asthma severity, skills, lung function
and quality of life were used to compare the educational
study group with the control group and to determine the
efficacy of the programme.
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Asthma severity outcome
Number of hospital admissions and emergency visits
during the previous 6 months: patients were asked to report
the number of hospitalizations and ER visits during the
previous 6 months.
Nocturnal symptoms: frequency of nocturnal symptoms,
based on how many times the patient experienced waking
up too early or waking up during the night because of
asthma symptoms over the previous 3 weeks before the
interview.
Frequency of symptoms scale: the frequency of diurnal
symptoms was scored using the following scale referring
to the previous 3 weeks: 0=absence of symptoms; 1=
symptoms present less than twice a week; 2=symptoms
present more than twice a week; 3=daily symptoms.
Skills
Adequate use of the MDI: the use of the MDI was
evaluated by a staff member using an eight step obser-
vational sequence scale recommended by MANZELLA et al.
[14] to analyse the use of inhaled medication. The patients
obtained a 10 when all steps were performed correctly, 5
when two steps were incorrectly performed, and 0 when
more than two steps were performed incorrectly.
Avoidance of triggering factors and environmental
control measures; the patients answered questions about
prophylactic actions regarding their triggering factors and
environmental challenges.
Difference between relief and prevention medication:
the patients were tested about their knowledge concerning
the recognition and use of drug medication. They were also
tested to see if they knew whether their medication was
used for relief or prevention.
Lung function
Peak expiratory flow rate (PEFR) pre- and post-
bronchodilator use: PEFR was measured before and after
bronchodilator use during each follow-up visit. The Assess
peak flow meter was used in accordance with standard
techniques [7]. In each step the highest value obtained
after three consecutive measurements was recorded and
the percentage of predicted values was calculated based
on the normogram of LEINER et al. [15].
Quality of life questionnaire
The asthma quality of life questionnaire based on
JuNIPER et al. [16] and JONES et al. [17] and adapted to the
authors' local situation demonstrated a good correlation
with severity of illness [18]. The questionnaire includes
five main areas: 1) limitation of the patient's physical ac-
tivities due to asthma symptoms; 2) frequency and
severity of symptoms; 3) adherence to treatment; 4) socio-
economic limitation; and 5) psychosocial limitation. The
questionnaire was applied during an interview because of
the high incidence of illiteracy among these patients.
Application of the questionnaire by the same investigator
required 15±20 min both at the beginning and at the end
of the 6 month programme.
The limitation of physical activity was evaluated by
means of three series of questions. In two of these, the
patient would choose five preferred activities which they
routinely performed. The following scale was used, 1
=mild; 2=moderate; and 3=severe, with a maximum total
score of 33 points. The frequency and severity of asthma
symptoms were evaluated using two questions (3 points
each) and the other areas were evaluated using standard
concordance/discordance answers, with total agreement=1,
total disagreement=0 and doubtful=0.5. The following
maximum points were obtained: adherence (6 points),
socioeconomic (11 points) and psychosocial (7 points).
The quality of life was calculated by the sum of the
points scored by the patients in each item and the average
in each area covered. The different points obtained in each
area were balanced by expressing the total points as
percentiles. The overall score was the percentile of total
points obtained for the entire questionnaire. Lower scores
indicated a better quality of life.
Statistical analysis
The outcomes for the evaluation of the efficacy of the
programme were compared by the Wilcoxon test (for the
same group) and the Mann-Whitney U-test (between
groups) for quantitative variables such as number of hos-
pital admissions, number of visits to the ER, sleep dis-
turbances due to asthma, frequency of symptoms, quality
of life score, score of MDI use, and PEFR. The McNemar,
Fisher exact test or Chi-squared test was used for qual-
itative variables such as avoidance of triggering factors,
environmental control measures, and understanding the
difference between relief and prevention medication. Sig-
nificance was defined as p<0.05.
Results
Of the 53 patients initially enrolled in the study, 11
(21%) were excluded because they did not complete the
trial; 5 withdrew from the educational group and 6 from the
control group. The analysis was then limited to 42 patients
who completed the protocol.
Table 1 shows the main characteristics of the subjects
included in the study. No significant differences were
observed regarding clinical, functional or socioeconomic
data between the educational and control groups. Overall,
more females than males entered the study.
Table 1. ± Baseline characteristics of patients in the edu-
cational and control groups
Educational
n=22
Control
n=20
Sex F/M 20/2 17/3
Age 4115 3817
Severe asthma % 36 35
Moderate asthma % 64 65
Comorbidity % 50 50
FEV1 % pred. 7022 8019
Monthly family income in US$ 486394 413233
Educational level 54 53
Illiterate % 9 10
<5 yrs of education % 73 60
>5 yrs of education % 18 30
Data are presented as meanSD unless otherwise indicated. F:
female; M: male; FEV1: forced expiratory volume in one
second.
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The educational and control groups had similar severity
parameters, skills, lung function and quality of life at
baseline assessment (tables 2 and 3).
Asthma severity
None of the patients in the educational group were
admitted to the hospital because of asthma exacerbation,
While this was necessary for 30% of the patients in the
control group (table 4). There was a borderline sig-
nificance when the groups were compared by the Mann-
Whitney U-test (p=0.08). The number of ER visits
decreased in both groups, but was significantly lower in
the educational group (p=0.03). The same results were
observed for nocturnal symptoms. Thirty per cent of
control patients woke up at least twice during the night
while this was true for only 9% of the patients in the
educational group.
The diurnal symptoms according to frequency of the
symptom scale were significantly-lower in the educational
group than in the control group (p=0.04). Seventy per cent
of the control group had diurnal symptoms scores of 2 and
3, while only 36% of the educational group had the same
scores.
Skills and knowledge
No differences were found in the proportion of patients
with a score of 10 in either group before intervention.
However, the patients from the educational group showed
significant improvement in the correct use of the MDI
(p<0.001). After the intervention, the proportion of patients
with a score of 10 increased from 4% to 77% in the edu-
cational group, while no improvement was observed in the
control group (table 5).
Seventy-three per cent of the patients in the educational
group correctly answered questions about prophylactic
actions regarding their triggering factors and environmen-
tal challenges, as opposed to only 35% of the control pa-
tients (p<0.05). Eighty-six per cent of the patients in the
educational group were able to recognise their medications
and knew whether they were taken for relief or prevention,
as opposed to only 20% of the control patients (p<0.05)
(table 5).
Lung function
After intervention, the patients in the educational group
showed significant improvement in prebronchodilator
PEFR (from 264 L.min-1 to 367 L.min-1 (p=0.003) and
in postbronchodilator PEFR from 345 L.min-1 to 401
L.min-1 (p=0.008) while the patients in the control group
showed no change in prebronchodilator PEFR before =
310 L.min-1, after = 323 L.min-1, (p=NS)) or postbronch-
odilator PEFR (before = 388 L.min-1 after = 401 L.min-1,
(p=NS)). However, no significant differences in PEFR were
observed between groups at the final evaluation (table 5).
Quality of life
After the intervention, both groups showed a significant
improvement in overall quality of life. However, compar-
ison of the groups at the end of the study showed better
scores for the quality of life of the educational group
(p=0.0005). (table 4).
Drug therapy
Table 6 shows the percentage of medication used by the
patients in both groups before and after the programme.
There was no significant difference in the percentage of
patients who used continuous oral steroids before and
after the programme. Three patients with moderate asth-
ma in the educational group and 1 patient in the control
group had been using self-medication with oral steroids.
The use of inhaled corticosteroids increased significantly
among the patients in the educational group, but remained
unchanged among the patients in the control group.
Table 2. ± Comparison of asthma severity, quality of life,
and outcomes before the intervention between edu-
cational and control groups
Educational
n=22
Control
n=20
p-value
Severity
Hospital admissions 0.41 0.71 0.23
Emergency room visits 45 44 0.52
Nocturnal symptoms
events.day-1 11.2 1.41.2 0.23
Frequency of the symptoms
score 2.50.7 2.50.8 0.79
Quality of life
Quality of life questionnaire
score 5114 5812 0.17
Physical limitation 5022 5614 0.27
Frequency and severity of
symptoms 7021 8017 0.15
Treatment adherence 3521 4225 0.31
Socioeconomic domain 4919 5918 0.14
Psychosocial domain 4925 5326 0.65
Data are presented as meanSD unless otherwise indicated. The
p-values were calculated from Mann-Whitney U-tests.
Table 3. ± Comparisons of skills, knowledge and lung
function outcomes before the intervention between the
educational and control groups
Educational
n=22
Control
n=20
p-value
Skills
Adequate use of
the MDI 23 34 NS
Patients with a score
of 10 4 15
Patients with a score
of 5 and 0 96 85
Knowledge rescue/
prevention medication 18 25 NS
Triggers/environmental
control 41 40 NS
Lung function
PEFR prebronchodilator
L.min-1 26490 310107 NS
PEFR postbronchodilator
L.min-1 34587 388103 NS
Data are presented as meanSD or as percentages. MDI: metered
dose inhaler; PEFR: peak expiratory flow rate; NS: non-
significant.
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Discussion
The programme, which was specially tailored for the
deprived socioeconomic situation of the target Brazilian
population, consisted of maximum optimization in health
care attendance and educational instructions.
The results confirmed previous findings that educational
programmes are feasible for the authors' population and
cause a decrease in morbidity parameters, with improved
management of asthma [13]. In order to evaluate the eff-
ectiveness of this educational programme, the authors'
included in the study patients with learning disabilities
and comorbidity seen at the University Hospital Centre. It
was decided not to test the ability of the patient to follow
a prescription as an inclusion criterion since this might
have excluded the patients more likely to be unresponsive
to the proposed treatment. The high number of unem-
ployed or part-time workers did not allow the estimation
of the real socioeconomic impact of the disease on the
study population.
Attendants were predominantly females showing the
same distribution as observed in the authors' Asthma Clin-
ic [19]. However, other reports have also shown similar
rates of female participants, ranging 60±76% [6, 20, 21].
It is not known whether this indicates more severe disease
among females or whether it is a result of females seeking
medical attention more frequently than males.
Initially, a high rate of ER visits, hospital admissions,
and high symptom scores that reflected poor disease con-
trol and a more limited lifestyle of the patients compared to
results from other studies was observed [22]. This may be
further attributed to the reference status of the hospital,
which treats a larger proportion of patients with severe
asthma. Also, the severity of asthma may have been the
result of socioeconomic, educational and psychological
background, factors that have been shown to increase
asthma morbidity [3, 23].
Patients were not provided with drugs because the
investigators wanted to simulate the situation in their public
health care system, which does not provide all medications
free of charge (inhaled steroids are rarely available). One of
the purposes of the study was to reinforce and highlight the
importance of each patient providing their own medication.
Interestingly, 95% of the patients in the educational group
were taking inhaled steroids after the intervention, a fact
that was not observed in the control group, treated by the
same medical team.
The impact of this asthma educational programme on
the morbidity of the study population was evident in terms
of most severity parameters. There was a decrease in hos-
pital admissions in the educational group, but due to the
small number of patients studied, this did not reach stat-
istical significance
When previous studies directed at socially deprived
populations were analysed, the current authors observed a
significant impact on morbidity, as described by MAYO et
al. [8]. These investigators demonstrated a reduction in
hospital readmission rates and hospital day use rates.
However, in their study the preventive medication was
supplied by the pharmacy, whereas in the current study
the asthmatic subjects paid for their own medication.
MAYO et al. [8] questioned the results of the programme.
If they had not supplied the medication to the patients,
would the results have been different? The current results
showed that interaction between the medical care
provider and the patients resulted in compliance with
treatment. The preventive medications were not available
at the pharmacy and the patients in the educational group
continued to use the appropriate medication whereas the
control group did not.
In a programme that emphasized the use of inhaled
corticosteroids combined with patient education, KELSO et
al. [10] also showed reduction in the ER visits and hos-
pitalizations.
Other controlled randomized clinical trials [24, 25] using
self-management plans have shown improved outcomes
in asthma morbidity but their target populations were not
comparable to the current population. LAHDENSUO et al.
[24] studied patients with mild and moderately severe
Table 4. ± Comparison of asthma severity, quality of life
outcomes after the intervention between educational and
control groups
Educational
n=22
Control
n=20
p-value
Severity
Hospital admissions 0 0.50.8 0.08
Emergency room visits 0.71.0 22 0.03
Nocturnal symptoms
events.day-1 0.30.5 0.71 0.04
Frequency of the symptoms
score 1.31 21 0.04
Quality of life
Quality of life questionnaire
score 2817 5015 0.0005
Physical limitation 2623 5119 0.002
Frequency and severity of
symptoms 3732 6925 0.002
Treatment adherence 1317 3425 0.007
Socioeconomic domain 3321 5320 0.004
Psychosocial domain 3218 4924 0.01
Data are presented as meanSD unless otherwise indicated. The
p-values were calculated from Mann-Whitney U-tests.
Table 5. ± Comparisons of skills, knowledge and lung
function outcomes after the intervention between the
educational and control groups
Educational
n=22
Control
n=20
p-value
Skills
Adequate use of
the MDI 83 44 0.001*
Patients with a score
of 10 77 25
Patients with a score
of 5 and 0 23 75
Knowledge rescue/
prevention medication 86 20 <0.05{
Triggers/environmental
control 73 35 <0.05{
Lung function
PEFR prebronchodilator
L.min-1 367137 323100 0.3*
PEFR postbronchodilator
L.min-1 401114 401119 0.5*
Data are presented as meanSD or as percentagess. *: Mann-
Whitney U-test; {: Fisher's exact or Chi-squared test. MDI:
metered dose inhaler; PEFR: peak expiratory flow rate.
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asthma but did not determine their socioeconomic level.
In Spain, IGNAÂ CIO-GARCIA and GONZALES-SANTOS [25]
studied patients of a higher socioeconomic level than the
current population.
In populations of a high socioeconomic level the im-
plementation of the educational programme led to im-
provement of patient information about asthma but did not
demonstrate a decrease in morbidity [22, 26]. These results
may indicate that patients with favourable socioeconomic
status and/or adequate prescriptions would not necessa-
rily need rigorous standardized educational programmes,
except in high risk groups, since the routine approach
offers the information necessary for good asthma control.
The reduction of morbidity may be due to a variety of
factors such as acquisition of knowledge, compliance with
treatment, adequacy of medical treatment, and especially
receiving more attention from the medical team. It is not
possible to determine from this study whether specific
features of the programme led to the reduction in asthma
morbidity. Undoubtedly the increased use of regularly in-
haled corticosteroids was the main cause of the improve-
ment in asthma morbidity in the educational group. In
addition, reduction of morbidity was due to the develop-
ment of good patient-doctor relationships leading to better
education.
In the educational group, patients showed a significant
improvement in knowledge about management of asthma
disease. Proper use of the inhaler and an appropriate
treatment schedule are important for achieving full benefit
from the medications. A significant increase in pre- and
postbronchodilator PEFR was observed in the educational
group but not in the control group. This effect on lung
function may possibly be explained by the change in drug
therapy that occurred in the intervention group.
In regard to quality of life, this improvement was more
pronounced in terms of limitation of physical activities and
frequency of symptoms, which was expected since these
reflect better control of the disease. The authors preferred
to use a questionnaire applied in the form of an interview
because many of the patients had difficulties in filling out
self-administered questionnaires. The most important vali-
dation of the questionnaire is a good association between
the score obtained and the severity of clinical asthma ex-
pression. In a previous report the authors have shown a
good correlation between the overall score obtained with
the questionnaire and the severity of illness, PEFR and
bronchial reversibility [18].
A brief comment is appropriate in regard to the
measurements. The authors did not require the patients
to fill out a complex diary card because most of them were
unable to do it without intensive training. The simple diary
card helped the patients to improve their perception of
asthma symptoms. In the study population, the presence of
asthma symptoms is often interpreted as normal, a fact
which has also been observed in other studies on low
income patients [27]. The main objective of the research
was to evaluate the effectiveness of an educational pro-
gramme specially designed for this population, taking
into consideration the unique characteristics of the pa-
tients such as illiteracy, difficulties in taking prescribed
medication and comorbidity.
Although the characteristics of the population were not
favourable for asthma education [28], a reduction in the
number of visits to the emergency room and in the
symptom scores, improvement of knowledge and quality
of life, and changes in medication compliance were all
observed. These findings support the theory that ed-
ucational programmes aimed at low-income populations
should be encouraged and developed to reduce asthma
morbidity. It is believed that educational asthma pro-
grammes should be implemented in order to more
effectively assist patients in the reduction of morbidity.
These programmes should also involve recycling and
updating on the part of the physicians, the improvement
of asthma management, and the allocation of increased
health care resources in order to reduce direct and indirect
cost.
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